Pathological roles of miRNAs and pseudogene-derived lncRNAs in human cancers, and their comparison as prognosis/diagnosis biomarkers
- PMID: 38128189
- DOI: 10.1016/j.prp.2023.155014
Pathological roles of miRNAs and pseudogene-derived lncRNAs in human cancers, and their comparison as prognosis/diagnosis biomarkers
Abstract
This review examines and compares the diagnostic and prognostic capabilities of miRNAs and lncRNAs derived from pseudogenes in cancer patients. Additionally, it delves into their roles in cancer pathogenesis. Both miRNAs and pseudogene-derived lncRNAs have undergone thorough investigation as remarkably sensitive and specific cancer biomarkers, offering significant potential for cancer detection and monitoring. . Extensive research is essential to gain a complete understanding of the precise roles these non-coding RNAs play in cancer, allowing the development of novel targeted therapies and biomarkers for improved cancer detection and treatment approaches.
Keywords: Biomarkers; Cancers; Diagnosis; MiRNAs; Pseudogene_derived LncRNA.
Copyright © 2023 Elsevier GmbH. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Pseudogenes and the associated ceRNA network as potential prognostic biomarkers for colorectal cancer.Sci Rep. 2022 Oct 22;12(1):17787. doi: 10.1038/s41598-022-22768-y. Sci Rep. 2022. PMID: 36272991 Free PMC article.
-
Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.World J Gastroenterol. 2015 Sep 14;21(34):9863-86. doi: 10.3748/wjg.v21.i34.9863. World J Gastroenterol. 2015. PMID: 26379393 Free PMC article. Review.
-
Identification of cancer-related potential biomarkers based on lncRNA-pseudogene-mRNA competitive networks.FEBS Lett. 2018 Mar;592(6):973-986. doi: 10.1002/1873-3468.13011. FEBS Lett. 2018. PMID: 29453881
-
Involvement of miRNAs and Pseudogenes in Cancer.Methods Mol Biol. 2018;1699:45-66. doi: 10.1007/978-1-4939-7435-1_3. Methods Mol Biol. 2018. PMID: 29086367 Review.
-
Non-coding RNAs as emerging regulators and biomarkers in colorectal cancer.Mol Cell Biochem. 2022 Jun;477(6):1817-1828. doi: 10.1007/s11010-022-04412-5. Epub 2022 Mar 24. Mol Cell Biochem. 2022. PMID: 35332394 Review.
Cited by
-
Targeting Regulatory Noncoding RNAs in Human Cancer: The State of the Art in Clinical Trials.Pharmaceutics. 2025 Apr 4;17(4):471. doi: 10.3390/pharmaceutics17040471. Pharmaceutics. 2025. PMID: 40284466 Free PMC article. Review.
-
The Role of the TIMP1/LINC01615 Axis as a Regulator of the EMT Pathway in Gastric Cancer.Biol Proced Online. 2025 Aug 18;27(1):31. doi: 10.1186/s12575-025-00297-y. Biol Proced Online. 2025. PMID: 40826020 Free PMC article.
-
HBx mutant-regulated RPL13AP25 mediates suboptimal virological response to entecavir and HCC progression.Cancer Cell Int. 2025 Jun 21;25(1):223. doi: 10.1186/s12935-025-03873-0. Cancer Cell Int. 2025. PMID: 40544238 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical